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Abstract
Background: A paper was published in a Chinese medical journal that suggested that the placing of an intact
vascularized omental pedicle would increase cerebral blood flow and could decelerate the development of
Alzheimer’s disease. However, the paper showed limited support for the operation. The purpose of this paper
is to suggest that the lack of enthusiasm for the operation may deserve re-evaluation.
Method: The operation that was evaluated required an intact omental pedicle to be placed directly on the
brain in order to increase the blood flow to the brain. The omentum is brought from the abdominal cavity
up to the brain where it is simply laid resulting in a large volume of blood to flow into the cerebral tissue.
Results: The Chinese paper demonstrated relatively poor results in the Alzheimer patients. It is believed that
the poor results were probably due to the results of the patients age, the length of time they had Alzheimer
disease (5 or more years), but especially their low mini-mental state examination results – some as low as 2.
Conclusion: The paper being presented will suggest the possible benefit of omental transposition in
Alzheimer patients when there is a successful choice of suitable candidates for the procedure.
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Omentum transposition to treat Alzheimer’s
disease in China
In 2007, the Journal of the Shanghai 2nd Medical Univer-
sity published a paper entitled, “Preliminary Study of
Omentum Transposition to Brain for Treatment of
Alzheimer’s Disease” [1]. The main authors were Zhong
J and WuWL. I was graciously included as an additional
author as I had participated in the cases reported in the
publication. I was unaware, however, of the article and
only learned of its existence years after its publication.
The authors concluded that placing the omentum on
the brain of Alzheimer patients could increase cerebral
blood flow (CBF) and could decelerate the development
of Alzheimer disease (AD). They cautioned however, that
the procedure is “potentially risky for the elderly.” The
apparent lack of enthusiasm for the operation has had a
chilling effect on Chinese general surgeons/neurosur-
geons who might consider performing omental transpos-
ition (OT) to the AD brain. The lack of support for the
procedure should be more clearly evaluated since the
operation has been shown to produce cognitive
improvement in humans [2, 3].
Physiological considerations
The decrease in cerebral blood flow in AD has been
confirmed by spin-related magnetic resonance imaging
and clearly relates the marked decrease in CBF as
compared to age-matched controls [4]. This decrease
in CBF in AD critically affects a host of physiological
conditions in the brain such as oxygenation, lower
glucose levels and an associated decrease in biological
agents that normally are delivered to the brain by
way of the bloodstream. This decrease in CBF is
especially deleterious to the survival of cerebral
neurons.
It has been commonly believed over the years that the
decrease in CBF in AD was due to dead and dying neu-
rons that no longer required a sustainable amount of
CBF. However, this CBF decrease in AD may not be due
to dying neurons that require less blood, but rather the
CBF decrease is the result of normal aging, high blood
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pressure, diabetes and other factors that eventually lead
to the death of neurons resulting in the cognitive defi-
ciency observed in AD.
Deteriorating neurons
If one considers the possibility that AD could be
caused by a decrease in loss of cerebral blood flow,
what would this effect have on neurons in an AD
brain? There are three types of neurons in the AD
brain - normal neurons; dead neurons that are the
hallmark of AD; and deteriorating neurons that are
viable in different stages of dying [5]. It seems rea-
sonable to expect that the greater the number of de-
teriorating neurons present in an AD brain, the
earlier is the stage of AD. Conversely, the fewer the
number of deteriorating neurons present in the later
stage of AD, the greater the number of dead neurons
that would be present. It would follow therefore, that
any form of treatment of AD should be initiated at
the earliest stage of AD when there would be a pre-
ponderance of viable deteriorating neurons.
It has been observed that in the entorinal cortex, in
the early stages of AD, 60 % of the neurons at the lamina
2 level are of the deteriorating type, and at the lamina 4
level, 40 % of the neurons are of the deteriorating type
[6]. The presence of such numbers of viable neurons in
the entorinal cortex is important since the entorinal cor-
tex is a critical cognitive location in the brain which is
commonly damaged in AD. Increasing CBF to the
deteriorating but still viable neurons early in AD may
explain the improved cognition that has been observed
in AD patients [7].
Neuronal survival
When neurons involved in cognition experience a de-
crease in cerebral blood flow, their biological activity
is adversely affected. This is true in the intra-
neuronal energy system that operates within cerebral
neurons, especially on the effect of a decrease in CBF
to intra-neuronal mitochondria. Mitochondria has a
direct effect on the production of adenosine triphos-
phate (ATP), that is the energy source for neurons.
Any reduction of ATP levels caused by a decrease in
CBF has a negative effect on intracellular protein me-
tabolism resulting in an accumulation of intracellu-
lar–extracellular amyloid B (AB) peptide in the AD
brain [8]. When neurons in specific and critical areas
of the brain (such as the hippocampus) begin to lose
their cellular energy because of decreased ATP, an
increase of CBF would likely benefit these neurons
because of increased intra-neuronal mitochondrial
activity, which would stimulate ATP production, the
energy source for a neuron.
Alzheimer’s disease evaluation
When one is considering surgery for an AD patient, it is
important that the patient be thoroughly evaluated phys-
ically and cognitively. Surgery should not be performed
simply because the patient has AD. An impartial medical
person should evaluate the physical condition of the
patient to determine whether the patient is a suitable
candidate for surgery. If the degree of AD is in an early
stage, a favorable outcome should be expected. Con-
versely, if a patient is in the late stages of AD, the
expectation of post-operative success is less favorable.
Additionally, if the patient is over 80, a favorable
outcome is less likely.
Mini Mental State Examination (MMSE)
The MMSE psychological test is an excellent way to de-
termine the loss of cognitive awareness in AD. Personal
experience has suggested that a high MMSE score raises
expectation that OT to the AD brain may improve cog-
nition. This is based on an apparent connection between
MMSE levels in AD patients and the number of deteri-
orating neurons present in an AD brain. The MMSE test
is based on a 1 – 30 scale. Twenty to thirty on an
MMSE scale indicates early AD; 16 – 20 on the scale
indicates moderately severe AD, and MMSE levels 15 or
lower indicates a severe state of AD. The connection be-
tween MMSE levels and the number of deteriorating
neurons in an AD brain is strongly suggested by the
results of the patients in the Chinese Paper.
Alzheimer’s disease treatment
There is presently no pharmaceutical agent that can in-
crease cerebral blood flow for an extended period. There
is however, a reported surgical procedure that can
greatly increase CBF. The operation involves placing the
omentum on the brain (called omentum transposition -
OT) in which the omentum is lengthened and brought
subcutaneously up the chest and neck to the head. A
craniotomy is performed and the omentum is simply
laid directly on the brain. No anastomosis is involved
and there is direct penetration of a large volume of
blood which flows from the omentum directly into
the brain [9].
Despite statements of proof that patients with AD
showed cognitive improvement following the surgery
[10], there is a belief held by some that AD is incurable.
This is based on the belief that AD is “irreversible be-
cause neurons that formally controlled cognitive func-
tion are largely dead and cannot be brought back to life”
[11]. Obviously dead neurons cannot be revived, but if
large numbers of viable deteriorating neurons are still
present at the time of OT, increased CBF may explain
why some patients have cognitively improved following
OT to their brain.
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Surgery
The procedure of omentum transposition (OT) requires
a laparotomy and a craniotomy. The patient is placed in
a supine position with his head turned to either left or
right depending on which side of the brain is to be cov-
ered by the omentum. An upper midline abdominal inci-
sion is made followed by the separation of the omentum
from its proximal and central attachments to the stom-
ach. Care must be taken that damage does not occur to
the gastro-epiploic artery that remains within the omen-
tal pedicle. After the omental pedicle has been lengthed
so that it can reach the top of the patients head, several
small transverse incisions are made along the chest wall.
These incisions are connected subcutaneously creating a
long tunnel that extends from the upper pole of the
mid-line abdominal incision up the chest wall and neck
to behind the ear.
While the omental lengthening process is being devel-
oped, a temporal-parietal craniotomy is simultaneously
carried out. The dura is opened and the omentum is
placed directly on the brain. The omentum is then
spread over the exposed brain area with the edges of the
dura being secured to the omentum. The bone flap of
the craniotomy is returned and the skin of the scalp is
closed in a routine fashion.
Discussion
Although the Chinese Paper [1] indicates that age and
physical health must be considered if a patient is suitable
for surgery, one must question whether the patients in
the Chinese study were suitable for a surgical procedure.
The paper stated that all the patients had suffered from
AD for more than five years, a time period that would
suggest that the brains of these patients had a scarcity of
deteriorating cerebral neurons and that the majority of
their critical cerebral neurons were dead. The majority
of the patients showed a post-operative increase in their
cerebral blood flow, but the CBF increase would have
had no effect on their non-viable cerebral neurons.
The Chinese patients were operated on because
they had Alzheimer’s disease. The importance of their
MMSE scores was not considered. At the time they
underwent surgery, no thought was raised as to the
possible relationship between the number of deterior-
ating neurons in their brain and the patients MMSE
score.
Information taken from the Chinese paper records the
post-operative results of the patients. Their low MMSE
scores, some as low as 2, would raise the question as to
whether post-operative success in some of the patients
could have been expected. The paucity of deteriorating
neurons in low MMSE patients who had suffered from
AD over a 5-year period may well explain the lack of
better post-operative result.
The information in the Chinese paper appears to sub-
stantiate a relationship between the number of deterior-
ating neurons and dead neurons found in the AD brain.
This observation strongly suggests the importance of
performing omentum transposition to the AD brain on
patients as early as possible and only when their MMSE
score is above 15-16.
Conclusion
It is known that millions of Chinese patients suffer from
AD and this number rises on a daily basis. If numerous
general and neuro-surgeons throughout China screen,
evaluate and select those patients who would likely
benefit from OT, it would be expected that favorable
cognitive results will result.
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